General Information of MIC (ID: MIC01961)
MIC Name Oscillibacter valericigenes (firmicutes)
Body Site Gut
Lineage Kingdom: Bacteria
Phylum: Firmicutes
Class: Clostridia
Order: Clostridiales
Family: Oscillospiraceae
Genus: Oscillibacter
Species: Oscillibacter valericigenes
Oxygen Sensitivity Anaerobe
Microbial Metabolism Fermentative
Gram Negative
Description Oscillibacter valericigenes is a Gram-negative and anaerobic bacterium. O. valericigenes has been detected in the human intestinal microbiome. In one study of human gut microflora, O. valericigenes was found in significantly more samples from healthy control test subjects than from patients diagnosed with Crohn's disease.
External Links Taxonomy ID
351091
Genome Assembly ID
ASM28357v1
GOLD Organism ID
Go0001120
Disease Relevance
          Crohn disease  [ICD-11: DD70]
             Description Uncultivated Oscillibacter strains have been previously found to be anti-correlated with Crohn's disease. [1]
          Depression  [ICD-11: 6A70]
             Description Oscillibacter was identified by more than one report as elevated in major depressive disorder. [2]
          Non-alcoholic fatty liver disease  [ICD-11: DB92]
             Description Nonalcoholic fatty liver disease was associated with Oscillibacter infection. [3]
          Obesity  [ICD-11: 5B81]
             Description Oscillibacter valericigenes was associated with genetic variants in Obesity. [4]
Host Genetic Factors (HGFs)
          15q11-13
             HGF ID HGF2318 HGF Info       Class Copy Number Variation: Gene Duplication (CNV-GDu)
             Description There has a significantly different abundance of Oscillibacter valericigenes between 15q dup mice and wild type littermates (p-value=0.0167). [5]
          MIR21
             HGF ID HGF2332 HGF Info       Class Copy Number Variation: Gene Deletion (CNV-GDe)
             Description The deletion of MIR-21 was significantly increased the abundance of Oscillibacter (p-value<0.05). [6]
          KLB
             HGF ID HGF2334 HGF Info       Class Copy Number Variation: Gene Deletion (CNV-GDe)
             Description The deletion of KLB reduced the proportion of Oscillibacter. [7]
Host Immune Factors (HIFs)
          Interleukin-1 beta
             HIF ID HIFM0138 HIF Info       Class Cytokine (Cyt)
             Description The Oscillibacter abundance was significantly positively correlated with IL-1beta levels. [8]
          Interferon-6
             HIF ID HIFM0151 HIF Info       Class Cytokine (Cyt)
             Description Oscillibacter abundance was significantly positively correlated with IL-6. [8]
Environmental Factor(s)
             Disbiome ID
      1576
             gutMDisorder ID
      gm0484
References
1 Cultivation-based multiplex phenotyping of human gut microbiota allows targeted recovery of previously uncultured bacteria. Nat Commun. 2014 Aug 28;5:4714. doi: 10.1038/ncomms5714.
2 Systematic Review of Gut Microbiota and Major Depression. Front Psychiatry. 2019 Feb 11;10:34. doi: 10.3389/fpsyt.2019.00034. eCollection 2019.
3 Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2013 Jul;11(7):868-75.e1-3. doi: 10.1016/j.cgh.2013.02.015. Epub 2013 Feb 27.
4 M-GWAS for the gut microbiome in Chinese adults illuminates on complex diseases. bioRxiv, 2019.
5 Altered microbiota composition reflects enhanced communication in 15q11-13 CNV mice.Neurosci Res. 2019 Dec 18:S0168-0102(19)30671-6. doi: 10.1016/j.neures.2019.12.010. Online ahead of print.
6 Loss of MicroRNA-21 Influences the Gut Microbiota, Causing Reduced Susceptibility in a Murine Model of Colitis.J Crohns Colitis. 2018 Jun 28;12(7):835-848. doi: 10.1093/ecco-jcc/jjy038.
7 -Klotho deficiency protects against obesity through a crosstalk between liver, microbiota, and brown adipose tissue.JCI Insight. 2017 Apr 20;2(8):e91809. doi: 10.1172/jci.insight.91809. eCollection 2017 Apr 20.
8 Phloretin ameliorates dextran sulfate sodium-induced ulcerative colitis in mice by regulating the gut microbiota. Pharmacol Res. 2019 Dec;150:104489. doi: 10.1016/j.phrs.2019.104489. Epub 2019 Nov 2.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.